Maravai Lifesciences Holdings, Inc. (MRVI)
7.32
+0.25
(+3.54%)
USD |
NASDAQ |
Oct 23, 16:00
7.32
0.00 (0.00%)
After-Hours: 20:00
Maravai Lifesciences Holdings Enterprise Value : 1.347B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.347B |
| October 22, 2026 | 1.310B |
| October 21, 2026 | 1.384B |
| October 20, 2026 | 1.329B |
| October 19, 2026 | 1.298B |
| October 16, 2026 | 1.268B |
| October 15, 2026 | 1.310B |
| October 14, 2026 | 1.232B |
| October 13, 2026 | 1.229B |
| October 12, 2026 | 1.308B |
| October 09, 2026 | 1.365B |
| October 08, 2026 | 1.331B |
| October 07, 2026 | 1.363B |
| October 06, 2026 | 1.426B |
| October 05, 2026 | 1.526B |
| October 02, 2026 | 1.433B |
| October 01, 2026 | 1.374B |
| September 30, 2026 | 1.398B |
| September 29, 2026 | 1.396B |
| September 28, 2026 | 1.393B |
| September 25, 2026 | 1.389B |
| September 24, 2026 | 1.396B |
| September 23, 2026 | 1.354B |
| September 22, 2026 | 1.368B |
| September 21, 2026 | 1.325B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.295B |
| September 17, 2026 | 1.339B |
| September 16, 2026 | 1.275B |
| September 15, 2026 | 1.281B |
| September 14, 2026 | 1.252B |
| September 11, 2026 | 1.229B |
| September 10, 2026 | 1.259B |
| September 09, 2026 | 1.292B |
| September 08, 2026 | 1.328B |
| September 04, 2026 | 1.347B |
| September 03, 2026 | 1.354B |
| September 02, 2026 | 1.356B |
| September 01, 2026 | 1.344B |
| August 31, 2026 | 1.395B |
| August 28, 2026 | 1.401B |
| August 27, 2026 | 1.503B |
| August 26, 2026 | 1.582B |
| August 25, 2026 | 1.597B |
| August 24, 2026 | 1.512B |
| August 21, 2026 | 1.543B |
| August 20, 2026 | 1.491B |
| August 19, 2026 | 1.332B |
| August 18, 2026 | 1.112B |
| August 17, 2026 | 1.103B |
| August 14, 2026 | 1.106B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.99B |
| Bio-Rad Laboratories, Inc. | 9.642B |
| Bruker Corp. | 10.43B |
| Azenta, Inc. | 1.323B |
| Danaher Corp. | 184.25B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.63M |
| Revenue (Quarterly) | 51.44M |
| Total Expenses (Quarterly) | 63.86M |
| EPS Diluted (Quarterly) | -0.0839 |
| Gross Profit Margin (Quarterly) | 40.14% |
| Profit Margin (Quarterly) | -42.05% |
| Earnings Yield | -7.27% |
| Normalized Earnings Yield | -1.186 |